Home/Filings/4/0001628280-24-029675
4//SEC Filing

Lecault Veronique 4

Accession 0001628280-24-029675

CIK 0001703057other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 6:38 PM ET

Size

9.9 KB

Accession

0001628280-24-029675

Insider Transaction Report

Form 4
Period: 2024-06-21
Lecault Veronique
DirectorChief Technology Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2024-06-21$0.19/sh+83,334$15,6672,123,456 total
  • Exercise/Conversion

    Share option (right to buy)

    2024-06-2183,3343,829,771 total
    Exercise: $0.19Exp: 2027-03-23Common Shares (83,334 underlying)
Holdings
  • Common Shares

    (indirect: See Footnote)
    273,630
  • Common Shares

    (indirect: By Spouse)
    61,580
  • Common Shares

    (indirect: See Footnote)
    7,155,008
Footnotes (3)
  • [F1]These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
  • [F2]These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
  • [F3]The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001834418

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:38 PM ET
Size
9.9 KB